U.S. House · 118th Congress · H.R. 5708

MCM PRV Reauthorization Act

To amend the Federal Food, Drug, and Cosmetic Act to extend a priority review program to encourage treatments for agents that present national security threats.

Follow

Log in to follow this bill and get an email when there’s a new vote (premium).

Sponsor
Brad FinstadR-MN-1
Introduced
September 26, 2023, in the House
Issue areas
Policy area
Health (from the Congressional Research Service)
Full text and actions
congress.gov

Votes on this bill (0)

Neither the House nor the Senate has held a roll-call vote on this bill.

Cosponsors (1)

1 Democrat. Each member is shown with the party they were counted with on the day they signed on. How we count these

Original cosponsors